Communications for Advocacy Opportunity Fund


The Communications for Advocacy Opportunity Fund (CAOF) makes small, timely investments to support high-impact communications opportunities to organizations and institutions whose mission is to advance policies and programs related to (a) the reproductive, maternal, newborn, child, and adolescent health and nutrition (RMNCAH+N) continuum of care and (b) strengthening delivery channels, including specific health areas such as malaria and HIV; vaccines; pneumonia; and/or enteric diarrheal diseases such as rotavirus, cholera, and typhoid.


Stakeholders in global health and development have made major investments in data-collection platforms and new research to improve the global community’s understanding of and ability to solve pressing development challenges. However, there is a gap between the production of the data and its use by advocates to effectively demonstrate to decision-makers and stakeholders in donor and developing countries which solutions drive the greatest impact.


CAOF seeks to address this gap by employing strategic communications to advance RMNCAH+N-related agenda-setting, policy, and financing priorities in donor (UK, Canada, Germany, France, and Sweden) and developing (Nigeria, Ethiopia, India, Kenya, Tanzania, Ouagadougou Partnership countries in Francophone West Africa, Pakistan, Indonesia, Bangladesh, and the Democratic Republic of Congo) countries. Successful applicants to this fund will be partnered with a communications agency to support their communications needs and goals. Investments will range between $50,000 and $75,000 and will be informed by each applicant’s needs and future conversations with partner communications agencies.


Criteria for applying to CAOF include:

  • Beneficiary organizations should be doing primary research or data analysis, and lack communications capacity
  • Data and evidence produced by applicants should be relevant to family planning; maternal, newborn, and child health; vaccine delivery; enteric and diarrheal diseases; and/or pneumonia
  • New data and evidence should have the potential to further critical advocacy goals for one of the aforementioned issues
  • Beneficiaries have received prior funding from the Bill & Melinda Gates Foundation


Click here to apply for a grant from CAOF.


1201 Connecticut Avenue NW, Suite 300, Washington, DC 20036 | 202-595-1061 | info[at]